Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-17 Sale | 2026-04-21 4:09 pm | INCYTE CORP | INCY | CAGNONI PABLO J President, Global Head of R&D | 18,667 | $96.5 | $1,801,366 | 317,224 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 4:20 pm | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 18,667 | $94.24 | $1,759,178 | 276,812 (Direct) | View |
| 2026-02-19 Sale | 2026-02-23 4:05 pm | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 18,668 | $100.91 | $1,883,788 | 258,250 (Direct) | View |
| 2023-02-01 Sale | 2023-02-01 9:41 pm | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J Director | 8,448 | $0.25 | $2,112 | 66,082 (Direct) | View |
| 2023-01-31 Sale | 2023-01-31 9:51 pm | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J Director | 7,240 | $0.241 | $1,745 | 192,030 (Direct) | View |
| 2022-02-01 Sale | 2022-02-01 9:20 pm | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President | 6,730 | $6.573 | $44,236 | 564,270 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-15 Tax Withholding | 2026-07-16 4:08 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, Global Head of R&D | 4,950 | $115.09 | 217,929 (Direct) | View |
| 2026-07-14 Tax Withholding | 2026-07-16 4:08 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, Global Head of R&D | 17,969 | $114.88 | 217,929 (Direct) | View |
| 2026-06-01 Tax Withholding | 2026-06-03 4:58 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, Global Head of R&D | 25,469 | $95.59 | 240,848 (Direct) | View |
| 2026-05-06 Option Award(A) | 2026-05-20 4:01 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, Global Head of R&D | 31,517 | $0 | 266,317 (Direct) | View |
| 2026-04-17 Exercise | 2026-04-21 4:09 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, Global Head of R&D | 12,590 | $71.93 | 317,224 (Direct) | View |
| 2026-04-17 Exercise | 2026-04-21 4:09 pm | N/A 2034-07-14 | INCYTE CORP | INCY | CAGNONI PABLO J President, Global Head of R&D | 18,667 | $0 | 317,224 (Direct) | View |
| 2026-04-17 Exercise | 2026-04-21 4:09 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, Global Head of R&D | 6,077 | $64.25 | 317,224 (Direct) | View |
| 2026-04-15 Option Award | 2026-04-17 4:12 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, Global Head of R&D | 27,892 | $0 | 262,692 (Direct) | View |
| 2026-03-17 Exercise | 2026-03-19 4:20 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 7,166 | $61.18 | 276,812 (Direct) | View |
| 2026-03-17 Exercise | 2026-03-19 4:20 pm | N/A 2034-01-17 | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 18,667 | $0 | 276,812 (Direct) | View |
| 2026-03-17 Exercise | 2026-03-19 4:20 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 11,501 | $64.25 | 276,812 (Direct) | View |
| 2026-02-19 Exercise | 2026-02-23 4:05 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 5,575 | $61.18 | 258,250 (Direct) | View |
| 2026-02-19 Exercise | 2026-02-23 4:05 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 13,093 | $61.76 | 258,250 (Direct) | View |
| 2026-02-19 Exercise | 2026-02-23 4:05 pm | N/A 2033-07-13 | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 18,668 | $0 | 258,250 (Direct) | View |
| 2026-01-16 Option Award | 2026-01-21 4:06 pm | N/A 2036-01-15 | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 28,475 | $0 | 28,475 (Direct) | View |
| 2025-07-15 Tax Withholding | 2025-07-16 4:05 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 2,628 | $68.25 | 318,117 (Direct) | View |
| 2025-07-15 Option Award | 2025-07-16 4:05 pm | N/A 2028-07-15 | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 100,855 | $0 | 318,117 (Direct) | View |
| 2025-07-14 Tax Withholding | 2025-07-16 4:05 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 1,280 | $69.98 | 318,117 (Direct) | View |
| 2025-01-17 Option Award | 2025-01-22 4:07 pm | N/A 2035-01-16 | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 40,289 | $0 | 40,289 (Direct) | View |
| 2024-07-15 Tax Withholding | 2024-07-17 12:28 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 749 | $64.25 | 265,581 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-17 12:28 pm | N/A 2034-07-14 | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 64,262 | $0 | 265,581 (Direct) | View |
| 2024-01-18 Option Award | 2024-01-22 1:04 pm | N/A 2034-01-17 | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 21,843 | $0 | 21,843 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-18 4:00 pm | N/A 2033-07-13 | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 29,943 | $0 | 222,343 (Direct) | View |
| 2023-06-05 Option Award(A) | 2023-06-21 4:00 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 192,400 | $0 | 192,400 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-14 5:05 pm | N/A 2033-06-13 | Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-05 Option Award | 2023-06-07 2:00 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 179,613 | $0 | 179,613 (Direct) | View |
| 2023-01-29 Exercise | 2023-01-31 9:51 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J Director | 46,250 | $0 | 192,030 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-22 7:05 pm | N/A 2032-06-13 | Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2021-04-26 Ownership | 2022-02-14 7:52 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President | 6,200 | $0 | 29,320 (Direct) | View |
| 2022-01-29 Exercise | 2022-02-01 9:20 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President | 21,250 | $0 | 564,270 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 9:20 pm | N/A 2032-01-30 | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President | 465,000 | $0 | 564,270 (Direct) | View |